EMEA-000100-PIP01-07-M01
Key facts
| Active substance |
Iron, aqua carbonate hydroxy oxo starch sucrose complex
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/64/2010
|
| PIP number |
EMEA-000100-PIP01-07-M01
|
| Pharmaceutical form(s) |
Powder for oral suspension
|
| Condition(s) / indication(s) |
Hyperphosphataemia in chronic kidney disease
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Novartis Europharm Limited
E-mail: paediatric.enquiries@novartis.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|